Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cervical cancer vaccines jointly win UK Prix Galien

This article was originally published in Scrip

Executive Summary

The UK Prix Galien Medal for Innovation has been awarded jointly to the two marketed cervical cancer vaccines,Sanofi-Pasteur MSD's Gardasil andGlaxoSmithKline's Cervarix. Other products highly commended for their innovation werePfizer's Champix andMS&D's Januvia, and commended products were Roche's Herceptin and MabThera, and Wyeth's Tygacil. The Prix Galien for orphan drug development was won by Novartis for Exjade, which is used to treat chronic iron overload in patients with thalassaemias. Commended orphans were GlaxoSmithKline's Atriance, Novartis's Tasigna, Bristol-Myers Squibb's Sprycel, Wyeth's Torisel and Encysive's Thelin. The judging panel was chaired by Sir Michael Rawlins, the chairman of the National Institute for health and Clinical Excellence.

You may also be interested in...



Janssen's Tremfya Gains Psoriatic Arthritis Indication In EU

The European Commission has extended the indications for Janssen’s Tremfya to include psoriatic arthritis, and those for BMS’s Opdivo to include gastroesophageal cancer.

Genmab Accelerates Priority Candidates, Ends Enapotamab Vedotin Development

Denmark’s biotech Genmab has dropped the AXL targeted antibody-drug conjugate, enapotamab vedotin from early clinical development, and is focusing its resources on other therapeutic programs.

Pipeline Watch: Phase III Readouts In Liver Diseases, COVID-19

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Topics

Related Companies

UsernamePublicRestriction

Register

LL018264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel